Aim
Uterine fibroids (UFs), commonly referred to as “leiomyomas,” are the most prevalent benign tumors in premenopausal females. They are often associated with infertility and recurrent miscarriage. The objective of this study was to assess the potential of cycloxygenase-2 (COX-2) gene polymorphism as a risk factor for fibroid development.
Patients and methods
This study involved 200 individuals, categorized into two groups: 100 patients with fibroids and 100 age-matched healthy females serving as the control group. Genotyping of the COX-2 (−765G>C) single nucleotide polymorphism (SNP) was conducted using the tetra-amplification refractory mutation system (T-ARMS) PCR technique.
Results
The genotype distribution patterns of the COX-2-765G>C SNP exhibited substantial variances between patients and control groups, with patients demonstrating a higher prevalence of the GC genotype (78 % versus 48 %, p < 0.001) and an increased frequency of the C-allele (47 % versus 26 %, p < 0.001). The examination of the dominant and over dominant models of the COX-2 (G>C-765) mutation demonstrated a substantial correlation with fibroid risk in comparison to controls (p < 0.001 and 0.001, respectively). The incidence of hysterectomy following fibroid diagnosis was markedly elevated in the dominant model group 3 (p = 0.02), whereas 3the incidence of myomectomy was much greater in the recessive model group (p < 0.001).
Conclusions
A substantial correlation was identified between the −765G>C SNP in the COX-2 gene and uterine leiomyoma in Egyptian females, indicating that its potential regulatory role merits further examination. Identifying the genes associated with UFs may result in novel medications and maybe the avoidance of this condition.
扫码关注我们
求助内容:
应助结果提醒方式:
